Japanese tech giant Olympus is shuttering its U.S. biotech business and looking to sell off the New Hampshire plant that makes the OP-1 bone growth putty it bought from Stryker in 2010, spelling layoffs for some 200 workers.
Olympus (PINK:OCPNY) said it's shutting down its U.S. biotech business after failing to "gain the traction necessary to build a broader regenerative medicine portfolio," meaning layoffs for the unit's 200 workers.
Analogic is on track with layoffs and facilities closures announced last year, but ALOG shares dive after the company reports disappointing earnings for its 2nd quarter and projects flat progress for the year ahead.
Symmetry Medical says it plans to close a plant in Cheltenham, England, this year, meaning job cuts for 40 workers.
Symmetry Medical's (NYSE:SMA) said it plans to close a plant in Cheltenham, England, this year, meaning layoffs for 40 workers there.
The Warsaw, Ind.-based medical device company said the plant makes medical instruments.
Medical device industry lobbying group AdvaMed reports that about 33,000 medtech jobs have been lost already as companies deal with the medical device sales tax.
The medical device industry has already lost some 33,000 jobs as a result of the medical device tax, according to a report from lobbying group AdvaMed.
Invacare winds down operations at a Canadian manufacturing facility in hopes of saving up to $2.7 million per year.
Medical device maker ConvaTec cuts 118 employees amid efforts to consolidate its New Jersey offices.
ConvaTec is cutting nearly 120 employees from its Skillman, N.J., headquarters and moving its operations to a smaller facility in the state, according to a local report.
Symmetry Medical begins consultation on closing a U.K. facility that houses 40 employees.
Indiana's Symmetry Medical (NYSE:SMA) reported this week that it's begun efforts to wind down operations at a Cheltenham, U.K. manufacturing plant, saying that it "initiated a consultation process" with the local employees.